MRNA News and Press, Moderna Inc. From 02/24/26

2026-02-24 12:06:38 ET More on Pfizer, Merck, etc. Merck: Why Investors Should Remain Bullish Despite Patent Risks Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) ...

WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc.  (NASDAQ: TECX) (“Tectonic”), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled r...

2026-02-23 09:20:00 ET Moderna (NASDAQ: MRNA) became a household name during the coronavirus pandemic. There's a good reason for that: Its mRNA technology enabled the rapid development of a vaccine. The financial benefit of that success for Moderna was huge, but what comes next? ...

2026-02-21 05:30:00 ET Billionaire Philippe Laffont is known for investing in technology winners. The founder of Coatue Management oversees $39 billion in 13F securities, and tech stocks are consistently at the top of his investment list. His four biggest holdings are in this industry, led ...

2026-02-20 09:09:42 ET More Related Stories This Is A Stock Picker's Market Amazon: Exploding CapEx, But Closer To Intrinsic Value AI Will Completely Transform Amazon Paramount’s bid for Warner Bros. clears U.S. antitrust waiting period Moderna...

2026-02-20 07:10:01 ET Moderna ( MRNA ) faces a lawsuit in the U.S. for allegedly infringing patent rights related to the COVID-19 shot developed by Pfizer ( PFE ) and BioNTech ( BNTX ), marking the latest such case among COVID-19 vaccine makers.... ...

2026-02-19 14:10:21 ET More on Pfizer, Sanofi, etc. Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game Pfizer: The Rebound Looks Unsustainable GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) China drug lic...

2026-02-19 13:31:04 ET More on AbbVie, AstraZeneca PLC, etc. Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game Pfizer: The Rebound Looks Unsustainable AbbVie: Dominating Immunology While Building Oncology Upside Merck posts n...

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / February 19, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 46 th Annual Healthcare Conference, on Tuesday, March 3 rd at 1:50pm ET Barclays 28 th Annual Global Hea...

2026-02-19 06:51:53 ET Listen below or on the go via Apple Podcasts and Spotify Carvana's (CVNA)Q4 profitability loses traction; shares crater more than 20%. (00:14) DoorDash ( DASH ) sees double-digit growth in orders, GOV; sets upbeat Q1 guidance. (01:3...